MGI Tech Co Ltd. Stock Analysis 688114.SS

MGI Tech Co., Ltd. engages in the research and development, production, and sale of DNA sequencing instruments, reagents, and related products to support life science research, agriculture, precision medicine and healthcare. The company is headquartered in Shenzhen, Guangdong and currently employs 2,195 full-time employees. The company went IPO on 2022-09-09. The firm mainly operates in three businesses. The gene sequencers and related equipment, sequencing reagents, and data processing systems. The laboratory automation products, including sample pretreatment products and automation platforms. The new business segments, including cell omics technology platforms, spatiotemporal omics platforms, and ultrasound imaging platforms, along with after-sales maintenance and product technical support services. The firm primarily operates in the domestic and overseas markets.